Rosiglitazone sodium
Based on 189 publication(s) in Google Scholar
Rosiglitazone sodium is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone sodium is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).
For research use only. We do not sell to patients.
- CAS No.: 316371-83-2
- Formula: C18H18N3NaO3S
- Molecular Weight:379.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Rosiglitazone sodium
More- Cancer Cell. 2024 May 13;42(5):869-884.e9. [Abstract]
- Cell. 2026 Jun 11;189(12):3571-3588.e27. [Abstract]
- Cell. 2026 May 28;189(11):3287-3305.e25. [Abstract]
- Circulation. 2023 Jan 10;147(2):158-174. [Abstract]
- Cell Metab. 2026 Mar 3;38(3):565-581.e5. [Abstract]
- Cell Metab. 2023 Dec 5;35(12):2165-2182.e7. [Abstract]
- Cell Metab. 2023 Nov 7;35(11):1915-1930.e8. [Abstract]
- Cell Metab. 2021 Mar 2;33(3):581-597.e9. [Abstract]
- Cancer Res. 2022 Apr 15;82(8):1503-1517. [Abstract]
- Nat Commun. 2025 Sep 10;16(1):8215. [Abstract]
- Nat Commun. 2023 Jun 2;14(1):3208. [Abstract]
- Nat Commun. 2023 May 15;14(1):2779. [Abstract]
- Cell Death Differ. 2025 Nov 27. [Abstract]
- Cell Death Differ. 2023 Mar;30(3):766-778. [Abstract]
- Acta Pharm Sin B. 2025 Dec;15(12):6382-6398. [Abstract]
- Adv Sci (Weinh). 2026 Mar 18:e22690. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(23):e15742. [Abstract]
- Adv Sci (Weinh). 2025 May;12(18):e2408724. [Abstract]
- Adv Sci (Weinh). 2025 Jan 30:e2413962. [Abstract]
- Adv Sci (Weinh). 2023 Sep;10(25):e2301088. [Abstract]
- Cardiovasc Res. 2026 Mar 24:cvag069. [Abstract]
- Theranostics. 2022 Nov 7;12(18):7699-7716. [Abstract]
- Theranostics. 2022 Jan 24;12(4):1904-1920. [Abstract]
- Chem Eng J. 2025 Oct 17;524:169708.
- Chem Eng J. 2023 Aug 6, 145212.
- Nucleic Acids Res. 2025 Jul 19;53(14):gkaf669. [Abstract]
- J Exp Clin Cancer Res. 2024 Dec 19;43(1):324. [Abstract]
- J Nanobiotechnology. 2026 Jun 2. [Abstract]
- J Nanobiotechnology. 2025 Jan 29;23(1):60. [Abstract]
- J Biomed Sci. 2025 May 30;32(1):54. [Abstract]
- Metabolism. 2025 Mar 30:156252. [Abstract]
- Redox Biol. 2023 Jun:62:102678. [Abstract]
- J Control Release. 2026 May 15:115026. [Abstract]
- J Hazard Mater. 2025 Apr 24:493:138407. [Abstract]
- EBioMedicine. 2026 Apr:126:106226. [Abstract]
- J Exp Med. 2022 May 2;219(5):e20211906. [Abstract]
- Pharmacol Res. 2020 Mar;153:104679. [Abstract]
- Cell Mol Biol Lett. 2022 Feb 2;27(1):11. [Abstract]
- Environ Int. 2024 Jan:183:108354. [Abstract]
- Cell Death Dis. 2024 Sep 29;15(9):695. [Abstract]
- Cell Death Dis.2024 May 21;15(5):350. [Abstract]
- Cell Death Dis. 2023 Dec 8;14(12):810. [Abstract]
- Cell Death Dis. 2023 Apr 6;14(4):246. [Abstract]
- J Pharm Anal. 2025 Dec;15(12):101307. [Abstract]
- J Pharm Anal. 2025 Jul;15(7):101182. [Abstract]
- Cell Commun Signal. 2023 Sep 30;21(1):268. [Abstract]
- Int J Biol Macromol. 2025 Dec 30;339(Pt 2):149976. [Abstract]
- Acta Pharmacol Sin. 2026 May 18. [Abstract]
- Acta Pharmacol Sin. 2023 Oct;44(10):2065-2074. [Abstract]
- Phytomedicine. 2025 Dec 28.
- EMBO J. 2025 Nov 20. [Abstract]
- Phytomedicine. 2025 Oct 11:148:157400. [Abstract]
- Free Radic Biol Med. 2026 Jun 8:254:31-45. [Abstract]
- Free Radic Biol Med. 2018 Oct:126:259-268. [Abstract]
- Sci Total Environ. 2023 Aug 25:888:164073. [Abstract]
- Sci Total Environ. 2023 Feb 1;858(Pt 1):159755. [Abstract]
- J Orthop Translat. 2026 Jun 23;59:101166. [Abstract]
- ACS Environ Au. 2025 Aug 5;5(6):573-582. [Abstract]
- Br J Pharmacol. 2020 May;177(10):2286-2302. [Abstract]
- Biomed Pharmacother. 2022 Oct:154:113653. [Abstract]
- Biomed Pharmacother. 2020 Sep;129:110356. [Abstract]
- Food Science and Human Wellness. 2023 Nov;12(6);2061-2072.
- Stem Cell Res Ther. 2024 May 1;15(1):127. [Abstract]
- Journal of Future Foods. 2025 Jul 8.
- Cell Death Discov. 2025 Jul 2;11(1):299. [Abstract]
- Cell Death Discov. 2022 Apr 30;8(1):236. [Abstract]
- Cell Rep. 2026 Jan 30;45(2):116929. [Abstract]
- Cell Rep. 2025 Dec 11;44(12):116678. [Abstract]
- Cell Rep. 2025 Nov 18;44(12):116577. [Abstract]
- Cell Rep. 2025 Jan 30;44(2):115251. [Abstract]
- Anal Chem. 2025 Jun 3;97(21):11099-11109. [Abstract]
- Mol Metab. 2024 Oct 29:102053. [Abstract]
- Antioxidants (Basel). 2024 Nov 24;13(12):1446. [Abstract]
- Mol Med. 2024 Nov 20;30(1):223. [Abstract]
- Compr Physiol. 2026 Jun;16(3):e70175. [Abstract]
- Phytother Res. 2025 Dec;39(12):5765-5776. [Abstract]
- Phytother Res. 2023 Feb;37(2):611-626. [Abstract]
- Cell Mol Life Sci. 2025 Nov 19;82(1):412. [Abstract]
- Ecotoxicol Environ Saf. 2025 Nov 15:307:119433. [Abstract]
- Ecotoxicol Environ Saf. 2025 Jan 22:290:117765. [Abstract]
- Ecotoxicol Environ Saf. 2022 Jun 15;238:113611. [Abstract]
- Cancer Cell Int. 2023 Aug 11;23(1):164. [Abstract]
- Environ Health. 2026 Jan 26.
- Eur J Med Chem. 2025 Oct 9:301:118226. [Abstract]
- Eur J Med Chem. 2025 Jan 15:286:117284. [Abstract]
- Eur J Med Chem. 2022 Feb 5:229:114061. [Abstract]
- Eur J Med Chem. 2021 Dec 5:225:113807. [Abstract]
- Ocul Surf. 2024 Oct:34:444-458. [Abstract]
- Cell Prolif. 2024 Jan;57(1):e13520. [Abstract]
- J Ethnopharmacol. 2026 Sep 15:368:121839. [Abstract]
- Inflamm Res. 2024 Oct;73(10):1765-1780. [Abstract]
- J Ethnopharmacol. 2024 Mar 1:321:117550. [Abstract]
- Food Funct. 2019 Dec 11;10(12):7983-7994. [Abstract]
- Cells. 2026 Apr 13;15(8):684. [Abstract]
- Cells. 2026 Feb 11;15(4):329. [Abstract]
- Cells. 2021 Dec 28;11(1):86. [Abstract]
- Commun Biol. 2024 Apr 9;7(1):429. [Abstract]
- Life Sci. 2021 Mar 15:269:119013. [Abstract]
- Nutrients. 2025 Feb 25;17(5):794. [Abstract]
- CNS Neurosci Ther. 2024 Nov;30(11):e70081. [Abstract]
- Int J Mol Sci. 2026 May 10;27(10):4255. [Abstract]
- Int J Mol Sci. 2025 Oct 18;26(20):10132. [Abstract]
- Int J Mol Sci. 2025 Apr 10;26(8):3553. [Abstract]
- J Zhejiang Univ Sci B. 2020;21(12):990-998. [Abstract]
- Pharmaceuticals (Basel). 2022 Aug 26;15(9):1055. [Abstract]
- Front Pharmacol. 2022 Jun 27;13:919202. [Abstract]
- Bioorg Chem. 2026 Jul 5:175:109764. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115739. [Abstract]
- Am J Physiol Cell Physiol. 2026 Jan 1;330(1):C142-C154. [Abstract]
- Eur J Pharmacol. 2025 Jun 5:996:177445. [Abstract]
- Eur J Pharmacol. 2023 Dec 5:960:176113. [Abstract]
- Bioorg Chem. 2022 Dec:129:106191. [Abstract]
- Eur J Pharmacol. 2022 Sep 15:931:175175. [Abstract]
- Int Immunopharmacol. 2021 Jan;90:107150. [Abstract]
- Eur J Pharmacol. 2020 Sep 5;882:173300. [Abstract]
- Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]
- Molecules. 2024 Oct 15;29(20):4881. [Abstract]
- Biomed J. 2025 Oct 9:100916. [Abstract]
- J Physiol Biochem. 2022 May;78(2):377-388. [Abstract]
- Front Cell Dev Biol. 2020 Jul 29;8:703. [Abstract]
- Poult Sci. 2026 Jan 18;105(4):106481. [Abstract]
- Exp Neurol. 2025 Oct 11:395:115486. [Abstract]
- Drug Dev Res. 2023 Aug;84(5):922-936. [Abstract]
- J Cell Mol Med. 2019 Oct;23(10):7029-7042. [Abstract]
- J Lipid Res. 2026 Feb;67(2):100981. [Abstract]
- iScience. 2026 Jan 7;29(2):114638. [Abstract]
- iScience. 2023 Feb 28;26(4):106289. [Abstract]
- iScience. 2022 Oct 10;25(11):105319. [Abstract]
- Front Mol Biosci. 2022 Feb 4;8:766887. [Abstract]
- J Cell Physiol. 2019 Nov;234(11):20694-20703. [Abstract]
- Aquaculture. 2026 Jan 4;615:743618.
- J Drug Target. 2025 Jul 17:1-10. [Abstract]
- Neuromolecular Med. 2025 Jan 27;27(1):12. [Abstract]
- J Biol Chem. 2024 Sep 12:107765. [Abstract]
- Sci Rep. 2024 Apr 30;14(1):9960. [Abstract]
- Aquaculture. 2024 Jan 15, 578, 740081.
- Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jul 13:125:110758. [Abstract]
- Biomedicines. 2021 Jun 15;9(6):677. [Abstract]
- Clin Immunol. 2026 Apr:284:110677. [Abstract]
- Food Sci Nutr. 2026 Jan 7;14(1):e71429. [Abstract]
- Food Sci Nutr. 2025 Sep 22;13(9):e71009. [Abstract]
- Front Mol Neurosci. 2017 Sep 14;10:293. [Abstract]
- Mol Cell Biochem. 2026 Mar 13. [Abstract]
- Cell Signal. 2022 May:93:110299. [Abstract]
- Exp Cell Res. 2026 Jun 9;461(1):115102. [Abstract]
- Exp Cell Res. 2026 May 1;458(1):114947. [Abstract]
- Meat and Muscle Biology. 2026.
- Front Physiol. 2019 Mar 1:10:165. [Abstract]
- Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Aug;1865(8):158711. [Abstract]
- Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E696-E708. [Abstract]
- PPAR Res. 2023 Nov 8:2023:6422804. [Abstract]
- PPAR Res. 2022 Sep 28:2022:7888937. [Abstract]
- Adipocyte. 2021 Dec;10(1):646-657. [Abstract]
- PPAR Res. 2019 Jul 1:2019:2715176. [Abstract]
- Ren Fail. 2022 Dec;44(1):2056-2065. [Abstract]
- Bioorg Med Chem. 2022 Feb 15:56:116615. [Abstract]
- J Therm Biol. 2024 Jul 2:123:103906. [Abstract]
- Front Vet Sci. 2023 Nov 17:10:1277586. [Abstract]
- Carcinogenesis. 2023 May 27;44(3):242-251. [Abstract]
- Am J Cancer Res. 2020 Apr 1;10(4):1182-1193. [Abstract]
- J Biochem Mol Toxicol. 2026 Feb;40(2):e70701. [Abstract]
- J Biochem Mol Toxicol. 2025 Oct;39(10):e70484. [Abstract]
- BMC Gastroenterol. 2025 Jan 20;25(1):22. [Abstract]
- Fish Physiol Biochem. 2025 Feb 15;51(2):51. [Abstract]
- J Cardiovasc Transl Res. 2024 Dec;17(6):1415-1426. [Abstract]
- Immunol Invest. 2022 May;51(4):1005-1022. [Abstract]
- Biochem Biophys Res Commun. 2026 Jul 23:823:153971. [Abstract]
- Biochem Biophys Res Commun. 2024 Nov 26:735:150865. [Abstract]
- Biochemistry (Mosc). 2021 May;86(5):568-576. [Abstract]
- Biochem Biophys Res Commun. 2020 Mar 26;524(1):70-76. [Abstract]
- Endocr J. 2022 Apr 28;69(4):385-397. [Abstract]
- Kidney Blood Press Res. 2021;46(5):601-612. [Abstract]
- Stem Cells Dev. 2022 Dec;31(23-24):799-809. [Abstract]
- Orthod Craniofac Res. 2025 Jun 28. [Abstract]
- Reprod Domest Anim. 2023 Nov;58(11):1559-1568. [Abstract]
- Open Med. 2024 Sep 3;19(1):20240993. [Abstract]
- Curr Med Sci. 2026 Feb;46(1):197-211. [Abstract]
- bioRxiv. 2025 Nov 3:2025.10.31.685966. [Abstract]
- SSRN. 2025 Aug 26.
- Res Sq. 2025 Aug 11.
- SSRN. 2025 Mar 18.
- SSRN. 2025 Feb 5.
- Preprints. 2024 Aug 23.
- hLife. 2024 Mar 2.
- Research Square Preprint. 2024 Feb 7.
- Research Square Print. 2022 Aug.
- Oxid Med Cell Longev. 2021 Oct 14;2021:5527137. [Abstract]
- Patent. US20180263995A1.
- Chinese Pharmacological Bulletin. 2017, 33(4): 517-521.
-
RT-PCR
-
WB
-
RT-PCR
-
WB
-
Cell Proliferation/Viability Assay
Biological Activity
|
PPARγ1 30 nM (EC50) |
PPARγ2 100 nM (EC50) |
Rosiglitazone sodium is a potent and selective activator of PPARγ, with EC50s of 30 nM and 100 nM for PPARγ1 and PPARγ2, respectively, and a Kd of appr 40 nM for PPARγ. Rosiglitazone (BRL49653, 0.1, 1,10 μM) promotes differentiation of C3H10T1/2 stem cells to adipocytes[1]. Rosiglitazone (Compound 6) activates PPARγ, with an EC50 of 60 nM[2]. Rosiglitazone (1 μM) activates PPARγ, which binds to NF-α1 promoter to activate gene transcription in neurons. Rosiglitazone (1 μM) also protects Neuro2A cells and hippocampal neurons against oxidative stress, and up-regulates BCL-2 expression in an NF-α1-dependent manner[3]. Rosiglitazone completely inhibits TRPM3 with IC50 values of 9.5 and 4.6 μM against nifedipine- and PregS-evoked activity, but such effects are not via PPARγ. Rosiglitazone inhibits TRPM2 at higher concentration, with an IC50 of appr 22.5 μM. Rosiglitazone is a strong stimulator of TRPC5 channels, with an EC50 of ∼30 μM[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 316371-83-2
-
Molecular Weight 379.41
-
Formula C18H18N3NaO3S
-
SMILES
O=C([N-]1)SC(CC2=CC=C(OCCN(C)C3=NC=CC=C3)C=C2)C1=O.[Na+]
-
Synonyms
BRL 49653 sodium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (189)
-
Journal Impact Factor
-
Most Recent
-
Cancer Cell
Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. [Abstract]2024 May 13;42(5):869-884.e9. PMID: 38579725 -
Cell
2026 Jun 11;189(12):3571-3588.e27. PMID: 42019490 -
Cell
2026 May 28;189(11):3287-3305.e25. PMID: 42054994 -
Circulation
Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries. [Abstract]2023 Jan 10;147(2):158-174. PMID: 36448459 -
Cell Metab
Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy. [Abstract]2026 Mar 3;38(3):565-581.e5. PMID: 41570815 -
Cell Metab
2023 Dec 5;35(12):2165-2182.e7. PMID: 38056430
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Dec 5;35(12):2165-2182.e7. [Abstract]
Relative GDF15 mRNA expression and GDF15 release in human primary hepatocytes treated with 10 μM rosiglitazone for 48 h.
-
Cell Metab
Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain. [Abstract]2023 Nov 7;35(11):1915-1930.e8. PMID: 37703873
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Nov 7;35(11):1915-1930.e8. [Abstract]
C3H10T1/2 preadipocytes were treated with differentiation medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nM Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days and subsequently cultured in maintaining medium supplemented with 1 nM Triiodothyronine, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were cultured in complete medium until used for experiments. Representative immunoblots of PGC-1α and UCP1 in beige adipocytes treated as indicated.
-
Cell Metab
2021 Mar 2;33(3):581-597.e9. PMID: 33440166
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2021 Mar 2;33(3):581-597.e9. [Abstract]
Protein expression of PPRC1 and PPARG in HepG2 cells exposed to PA and treated with RGZ (Rosiglitazone) (30 mmol/L; 24 h), as analyzed by western blot.
-
Cancer Res
Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer. [Abstract]2022 Apr 15;82(8):1503-1517. PMID: 35255118 -
Nat Commun
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. [Abstract]2025 Sep 10;16(1):8215. PMID: 40931013
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Sep 10;16(1):8215. [Abstract]
NECTIN4 mRNA levels in RT112 cells treated with 1μM Rosiglitazone and T0070907 (T007) for 72 h.
-
Nat Commun
Senescent immune cells accumulation promotes brown adipose tissue dysfunction during aging. [Abstract]2023 Jun 2;14(1):3208. PMID: 37268694
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Jun 2;14(1):3208. [Abstract]
C3H10T1/2 preadipocytes were cultured in DMEM supplemented with 10% FBS, 1% P/S. For adipogenic differentiation, confluent C3H10T1/2 preadipocytes were incubated with complete medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nm Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days. Then, cells were changed to the complete medium supplemented with 1 nM T3, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were maintained in complete medium until used for experiments. Representative immunoblots of NRP1 and EPHA7 in differentiated brown adipocytes transfected with si-Rbm3 or si-NC.
-
Nat Commun
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models. [Abstract]2023 May 15;14(1):2779. PMID: 37188705 -
Cell Death Differ
Epigenetic regulation of ACSL4 via H2A monoubiquitylation connects lipid metabolism to BAP1-mediated ferroptosis. [Abstract]2025 Nov 27. PMID: 41310183 -
Cell Death Differ
Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions. [Abstract]2023 Mar;30(3):766-778. PMID: 36329235 -
Acta Pharm Sin B
2025 Dec;15(12):6382-6398. PMID: 41477334 -
Adv Sci (Weinh)
Cars2-Mediated Cysteine Catabolism Drives Brown Fat Development and Thermogenesis Through Persulfidating EBF2. [Abstract]2026 Mar 18:e22690. PMID: 41849685 -
Adv Sci (Weinh)
SR-B1-Mediated Transplacental Transfer of Hydrophobic Toxicants Disrupts Fetal Development During Barriergenesis. [Abstract]2026 Apr;13(23):e15742. PMID: 41736660 -
Adv Sci (Weinh)
FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration. [Abstract]2025 May;12(18):e2408724. PMID: 40091484 -
Adv Sci (Weinh)
Photothermal-Responsive Soluble Microneedle Patches for Meibomian Gland Dysfunction Therapy. [Abstract]2025 Jan 30:e2413962. PMID: 39887671 -
Adv Sci (Weinh)
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer. [Abstract]2023 Sep;10(25):e2301088. PMID: 37428466 -
Cardiovasc Res
METTL14 inhibits atherogenesis by epigenetically activating PPAR-α/γ transcription and fatty acid oxidation in VSMCs. [Abstract]2026 Mar 24:cvag069. PMID: 41873711 -
Theranostics
SOX4 promotes beige adipocyte-mediated adaptive thermogenesis by facilitating PRDM16-PPARγ complex. [Abstract]2022 Nov 7;12(18):7699-7716. PMID: 36451857 -
Theranostics
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer. [Abstract]2022 Jan 24;12(4):1904-1920. PMID: 35198079 -
-
-
Nucleic Acids Res
PPARG-centric transcriptional re-wiring during differentiation of human trophoblast stem cells into extravillous trophoblasts. [Abstract]2025 Jul 19;53(14):gkaf669. PMID: 40705926 -
J Exp Clin Cancer Res
SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis. [Abstract]2024 Dec 19;43(1):324. PMID: 39702326 -
J Nanobiotechnology
Suppression of senescent metabolism of adipose tissue by rebalancing mitochondrial homeostasis via a selective drug delivery system. [Abstract]2026 Jun 2. PMID: 42231423 -
J Nanobiotechnology
CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis. [Abstract]2025 Jan 29;23(1):60. PMID: 39881299 -
J Biomed Sci
USP24 upregulation stabilizes PKA-Cα to promote lipogenesis, inflammation, and fibrosis during MASH progression. [Abstract]2025 May 30;32(1):54. PMID: 40448065 -
Metabolism
Prevention of insulin-induced lipohypertrophy by coadministration of a low dose of high-affinity PI3K inhibitors. [Abstract]2025 Mar 30:156252. PMID: 40169086 -
Redox Biol
Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment. [Abstract]2023 Jun:62:102678. PMID: 36940607 -
J Control Release
Metabolism-modulating nanoparticles for remodeling adipose-liver crosstalk to reverse liver fibrosis. [Abstract]2026 May 15:115026. PMID: 42142745 -
J Hazard Mater
Underlying mechanisms of metabolic dysfunction-associated steatotic liver disease induced by 2-ethylhexyl diphenyl phosphate and its hydroxylated metabolite in zebrafish (Danio rerio). [Abstract]2025 Apr 24:493:138407. PMID: 40300519 -
EBioMedicine
PPAR-γ suppresses macrophage senescence and allergic airway inflammation through controlling lipid metabolic pathways. [Abstract]2026 Apr:126:106226. PMID: 41864062 -
J Exp Med
Intermittent prednisone treatment in mice promotes exercise tolerance in obesity through adiponectin. [Abstract]2022 May 2;219(5):e20211906. PMID: 35363257 -
Pharmacol Res
A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice. [Abstract]2020 Mar;153:104679. PMID: 32014571 -
Cell Mol Biol Lett
2022 Feb 2;27(1):11. PMID: 35109789 -
Environ Int
Adipogenic and osteogenic effects of OBS and synergistic action with PFOS via PPARγ-RXRα heterodimers. [Abstract]2024 Jan:183:108354. PMID: 38043320 -
Cell Death Dis
ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma. [Abstract]2024 Sep 29;15(9):695. PMID: 39343834 -
Cell Death Dis
Seipin deficiency-induced lipid dysregulation leads to hypomyelination-associated cognitive deficits via compromising oligodendrocyte precursor cell differentiation. [Abstract]2024 May 21;15(5):350. PMID: 38773070 -
Cell Death Dis
Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis. [Abstract]2023 Dec 8;14(12):810. PMID: 38065978 -
Cell Death Dis
2023 Apr 6;14(4):246. PMID: 37024456 -
J Pharm Anal
1,8-Cineole ameliorates vascular endothelial senescence in diabetes mellitus by directly targeting and deubiquitinating PPAR-γ in vivo and in vitro. [Abstract]2025 Dec;15(12):101307. PMID: 41492461 -
J Pharm Anal
Effect of cholesterol on distribution, cell uptake, and protein corona of lipid microspheres at sites of cardiovascular inflammatory injury. [Abstract]2025 Jul;15(7):101182. PMID: 40735031 -
Cell Commun Signal
Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis. [Abstract]2023 Sep 30;21(1):268. PMID: 37777801 -
Int J Biol Macromol
2025 Dec 30;339(Pt 2):149976. PMID: 41478474 -
Acta Pharmacol Sin
Few-shot learning-driven discovery of Lutein suppresses Th1-mediated inflammation via glucose metabolism. [Abstract]2026 May 18. PMID: 42144445 -
Acta Pharmacol Sin
Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway. [Abstract]2023 Oct;44(10):2065-2074. PMID: 37225845 -
-
EMBO J
2025 Nov 20. PMID: 41266655 -
Phytomedicine
Perillyl alcohol ameliorates high-fat diet-induced obesity in mice by modulating gut microbiota and activating IRF4-mediated brown fat thermogenesis. [Abstract]2025 Oct 11:148:157400. PMID: 41138577 -
Free Radic Biol Med
Thiomyristoyl promotes type 2 diabetic wound healing and inhibits scarring via the PPARγ/Sirt3/SOD2 axis. [Abstract]2026 Jun 8:254:31-45. PMID: 42264197 -
Free Radic Biol Med
2018 Oct:126:259-268. PMID: 30138713
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2018 Oct:126:259-268. [Abstract]
Laser confocal microscope is performed to measure MMP indicated with the ratio of JC-1 Red/JC-1 Green. Nuclei are counterstained with DAPI (blue). Bar graphs represent the mean ± SD of red/green fluorescence intensity.
-
Sci Total Environ
UV filter ethylhexyl salicylate affects cardiovascular development by disrupting lipid metabolism in zebrafish embryos. [Abstract]2023 Aug 25:888:164073. PMID: 37201812 -
Sci Total Environ
Antibiotics disrupt lipid metabolism in zebrafish (Danio rerio) larvae and 3T3-L1 preadipocytes. [Abstract]2023 Feb 1;858(Pt 1):159755. PMID: 36349636 -
J Orthop Translat
Semaglutide alleviates osteoarthritis independent of weight loss via GLP-1R-mediated activation of autophagy through AKT/mTOR inhibition. [Abstract]2026 Jun 23;59:101166. PMID: 42381999 -
ACS Environ Au
Machine Learning-Assisted Recognition of Environmental Sulfur-Containing Chemicals in Nontargeted Mass Spectrometry Analysis of Inadequate Mass Resolution. [Abstract]2025 Aug 5;5(6):573-582. PMID: 41277996 -
Br J Pharmacol
HWL-088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in ob/ob diabetic mice. [Abstract]2020 May;177(10):2286-2302. PMID: 31971610 -
Biomed Pharmacother
Identification of a novel PPARγ modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation. [Abstract]2022 Oct:154:113653. PMID: 36942599 -
Biomed Pharmacother
PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway. [Abstract]2020 Sep;129:110356. PMID: 32535388 -
-
Stem Cell Res Ther
MSCs promote the efferocytosis of large peritoneal macrophages to eliminate ferroptotic monocytes/macrophages in the injured endometria. [Abstract]2024 May 1;15(1):127. PMID: 38693589 -
-
Cell Death Discov
DNMBP-AS1/hsa-miR-30a-5p/PGC1α axis suppresses tumor progression of colorectal cancer by inhibiting PKM2-mediated Warburg effect and enhance anti-PD-1 therapy efficacy. [Abstract]2025 Jul 2;11(1):299. PMID: 40603870 -
Cell Death Discov
Disturbance of calcium homeostasis and myogenesis caused by TET2 deletion in muscle stem cells. [Abstract]2022 Apr 30;8(1):236. PMID: 35490157 -
Cell Rep
NAD+ sensing by PARP7 regulates the C/EBPβ-dependent transcription program during adipogenesis. [Abstract]2026 Jan 30;45(2):116929. PMID: 41621069 -
Cell Rep
Paracrine stimulation of brown adipose tissue vascularization by adipocyte O-GlcNAc signaling. [Abstract]2025 Dec 11;44(12):116678. PMID: 41385373 -
Cell Rep
Blocking glycogen synthase 1 in white adipose tissue alleviates hypermetabolism following severe burn injury through inhibition of JAK2 by UDPG. [Abstract]2025 Nov 18;44(12):116577. PMID: 41259203 -
Cell Rep
Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling. [Abstract]2025 Jan 30;44(2):115251. PMID: 39891907 -
Anal Chem
Exposome-Scale Investigation of Cl-/Br-Containing Chemicals Using High-Resolution Mass Spectrometry, Multistage Machine Learning, and Cloud Computing. [Abstract]2025 Jun 3;97(21):11099-11109. PMID: 40401576 -
Mol Metab
RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis. [Abstract]2024 Oct 29:102053. PMID: 39481849 -
Antioxidants (Basel)
Ginsenoside Rg1 Alleviates Blood-Milk Barrier Disruption in Subclinical Bovine Mastitis by Regulating Oxidative Stress-Induced Excessive Autophagy. [Abstract]2024 Nov 24;13(12):1446. PMID: 39765775 -
Mol Med
Elabela alleviates cuproptosis and vascular calcification in vitaminD3- overloaded mice via regulation of the PPAR-γ /FDX1 signaling. [Abstract]2024 Nov 20;30(1):223. PMID: 39567863 -
Compr Physiol
The Acyltransferase Transmembrane Protein 68 Promotes Neutral Lipid Storage in Mouse Adipocytes. [Abstract]2026 Jun;16(3):e70175. PMID: 42148591 -
Phytother Res
Pinoresinol Diglucoside Alleviates Cardiac Fibrosis Through Inhibiting Endothelial-Mesenchymal Transition via the Transforming Growth Factor-β1/Smads Pathway in db/db Mice. [Abstract]2025 Dec;39(12):5765-5776. PMID: 41188687 -
Phytother Res
Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease. [Abstract]2023 Feb;37(2):611-626. PMID: 36325883 -
Cell Mol Life Sci
Myogenic enhancer snatching promotes adipogenic differentiation during epigenetic reprogramming mediated by lineage-specific transcription factors. [Abstract]2025 Nov 19;82(1):412. PMID: 41258103 -
Ecotoxicol Environ Saf
PPARγ-responsive luciferase reporter system for high-throughput screening of chemical toxins with potential pulmonary fibrosis effects. [Abstract]2025 Nov 15:307:119433. PMID: 41273832 -
Ecotoxicol Environ Saf
Effects of benzotriazoles UV-328, UV-329, and UV-P on the self-renewal and adipo-osteogenic differentiation of human mesenchymal stem cells. [Abstract]2025 Jan 22:290:117765. PMID: 39847882 -
Ecotoxicol Environ Saf
Excessive selenium affects neural development and locomotor behavior of zebrafish embryos. [Abstract]2022 Jun 15;238:113611. PMID: 35526456 -
Cancer Cell Int
Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic model. [Abstract]2023 Aug 11;23(1):164. PMID: 37568192 -
-
Eur J Med Chem
Design, synthesis and anti-diabetic evaluation of novel PPAR agonists based on functional group-oriented strategy. [Abstract]2025 Oct 9:301:118226. PMID: 41075607 -
Eur J Med Chem
Design, synthesis, and biological evaluation of imidazolidinone derivatives as potent PPARα/δ agonists for the treatment of cholestatic liver diseases. [Abstract]2025 Jan 15:286:117284. PMID: 39827490 -
Eur J Med Chem
Discovery of new and highly effective quadruple FFA1 and PPARα/γ/δ agonists as potential anti-fatty liver agents. [Abstract]2022 Feb 5:229:114061. PMID: 34954593 -
Eur J Med Chem
Discovery of the first-in-class dual PPARδ/γ partial agonist for the treatment of metabolic syndrome. [Abstract]2021 Dec 5:225:113807. PMID: 34455359 -
Ocul Surf
2024 Oct:34:444-458. PMID: 39395739 -
Cell Prolif
Decreased YB-1 expression denervates brown adipose tissue and contributes to age-related metabolic dysfunction. [Abstract]2024 Jan;57(1):e13520. PMID: 37321837 -
J Ethnopharmacol
Euphorbia humifusa Willd. alleviates ulcerative colitis by inhibiting lipid peroxidation via ACSL4/COX-2 axis. [Abstract]2026 Sep 15:368:121839. PMID: 42106018 -
Inflamm Res
Rosiglitazone attenuates Acute Kidney Injury from hepatic ischemia-reperfusion in mice by inhibiting arachidonic acid metabolism through the PPAR-γ/NF-κB pathway. [Abstract]2024 Oct;73(10):1765-1780. PMID: 39112648 -
J Ethnopharmacol
Essential oil from Fructus Alpiniae zerumbet ameliorates vascular endothelial cell senescence in diabetes by regulating PPAR-γ signalling: A 4D label-free quantitative proteomics and network pharmacology study. [Abstract]2024 Mar 1:321:117550. PMID: 38065350 -
Food Funct
Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPARγ-NF-κB signaling pathway. [Abstract]2019 Dec 11;10(12):7983-7994. PMID: 31773117 -
Cells
Oleic Acid and Transferrin Synergistically Induce Serum-Free Adipogenic Differentiation of Porcine Preadipocytes via the SEPTIN4/PPARγ Axis. [Abstract]2026 Apr 13;15(8):684. PMID: 42041552 -
Cells
The Asp-Encoding Gene FBN1 Mediates Cold Adaptation in Sunite Sheep by Reprogramming Adipocyte Differentiation Towards Thermogenesis. [Abstract]2026 Feb 11;15(4):329. PMID: 41744772 -
Cells
2021 Dec 28;11(1):86. PMID: 35011648 -
Commun Biol
PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis. [Abstract]2024 Apr 9;7(1):429. PMID: 38594496 -
Life Sci
Combination therapy with semaglutide and rosiglitazone as a synergistic treatment for diabetic retinopathy in rodent animals. [Abstract]2021 Mar 15:269:119013. PMID: 33417950 -
Nutrients
Medium-Chain Fatty Acids Selectively Sensitize Cancer Cells to Ferroptosis by Inducing CD36 and ACSL4. [Abstract]2025 Feb 25;17(5):794. PMID: 40077664 -
CNS Neurosci Ther
The Neuroprotective Mechanisms of PPAR-γ: Inhibition of Microglia-Mediated Neuroinflammation and Oxidative Stress in a Neonatal Mouse Model of Hypoxic-Ischemic White Matter Injury. [Abstract]2024 Nov;30(11):e70081. PMID: 39496476 -
Int J Mol Sci
Establishment and Comparative Analysis of Four Mouse Models for the Study of Pancreatic Steatosis. [Abstract]2026 May 10;27(10):4255. PMID: 42196238 -
Int J Mol Sci
2025 Oct 18;26(20):10132. PMID: 41155424 -
Int J Mol Sci
Inhibition of ACSL4 Attenuates Behavioral Deficits by Regulating Ferroptosis in a Murine Model of Systemic Lupus Erythematosus. [Abstract]2025 Apr 10;26(8):3553. PMID: 40332005 -
J Zhejiang Univ Sci B
Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model. [Abstract]2020;21(12):990-998. PMID: 33843164 -
Pharmaceuticals (Basel)
Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo. [Abstract]2022 Aug 26;15(9):1055. PMID: 36145276 -
Front Pharmacol
Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats. [Abstract]2022 Jun 27;13:919202. PMID: 35833024 -
Bioorg Chem
Discovery of Tetrazolone derivatives as potent PPARα/δ dual agonists for metabolic dysfunction-associated steatohepatitis. [Abstract]2026 Jul 5:175:109764. PMID: 41880786 -
Int Immunopharmacol
Trem2 prevents adverse pregnancy outcomes induced by Toxoplasma gondii by promoting PPARγ-mediated P-STAT6 signaling. [Abstract]2026 Jan 1;168(Pt 1):115739. PMID: 41175738 -
Am J Physiol Cell Physiol
2026 Jan 1;330(1):C142-C154. PMID: 41269663 -
Eur J Pharmacol
The therapeutic potential of Rosiglitazone in modulating scar formation through PPAR-γ pathway. [Abstract]2025 Jun 5:996:177445. PMID: 40054722 -
Eur J Pharmacol
GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota. [Abstract]2023 Dec 5:960:176113. PMID: 37838102 -
Bioorg Chem
Structure-based screening and biological validation of the anti-thrombotic drug-dicoumarol as a novel and potent PPARγ-modulating ligand. [Abstract]2022 Dec:129:106191. PMID: 36270169 -
Eur J Pharmacol
Proteomic analysis reveals that ACSL4 activation during reflux esophagitis contributes to ferroptosis-mediated esophageal mucosal damage. [Abstract]2022 Sep 15:931:175175. PMID: 35921957 -
Int Immunopharmacol
LncRNA SNHG7 alleviates IL-1β-induced osteoarthritis by inhibiting miR-214-5p-mediated PPARGC1B signaling pathways. [Abstract]2021 Jan;90:107150. PMID: 33296783 -
Eur J Pharmacol
Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor α/δ agonist, in rodent model of nonalcoholic steatohepatitis. [Abstract]2020 Sep 5;882:173300. PMID: 32592770 -
Eur J Pharmacol
MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models. [Abstract]2019 Jan 15:843:134-144. PMID: 30412727
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]
Protein levels of BACE1 and APP are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]
Protein levels of sAPPα and sAPPβ are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]
PPARγ level is determined by IF assay in 3×Tg-AD mice, 3×Tg-AD mice with RSG treatment, 3×Tg-AD-KO mice, 3×Tg-AD-KO mice with GW9662 stimulation.
-
Molecules
Identification of Novel PPARγ Partial Agonists Based on Virtual Screening Strategy: In Silico and In Vitro Experimental Validation. [Abstract]2024 Oct 15;29(20):4881. PMID: 39459249 -
Biomed J
Inhibition of the 4-hydroxynonenal-regulated JNK/c-Jun pathway improves bleomycin-induced lung fibrosis. [Abstract]2025 Oct 9:100916. PMID: 41076274 -
J Physiol Biochem
Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis : Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis. [Abstract]2022 May;78(2):377-388. PMID: 35122619 -
Front Cell Dev Biol
2020 Jul 29;8:703. PMID: 32850823 -
Poult Sci
Three alternative promoters govern PGC-1α expression in chicken and are directly repressed by PPARγ. [Abstract]2026 Jan 18;105(4):106481. PMID: 41610606 -
Exp Neurol
RvD1 signaling in peripheral macrophages promotes systemic β-amyloid clearance to mitigate the progression of perioperative neurocognitive disorders in mice. [Abstract]2025 Oct 11:395:115486. PMID: 41082997 -
Drug Dev Res
Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis. [Abstract]2023 Aug;84(5):922-936. PMID: 37052239 -
J Cell Mol Med
Hoxa5 alleviates obesity-induced chronic inflammation by reducing ER stress and promoting M2 macrophage polarization in mouse adipose tissue. [Abstract]2019 Oct;23(10):7029-7042. PMID: 31441588 -
J Lipid Res
2026 Feb;67(2):100981. PMID: 41565113 -
iScience
Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioning. [Abstract]2026 Jan 7;29(2):114638. PMID: 41623495 -
iScience
Suppression of preadipocyte determination by SOX4 limits white adipocyte hyperplasia in obesity. [Abstract]2023 Feb 28;26(4):106289. PMID: 36968079 -
iScience
Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19. [Abstract]2022 Oct 10;25(11):105319. PMID: 36246577 -
Front Mol Biosci
2022 Feb 4;8:766887. PMID: 35187064 -
J Cell Physiol
PPARγ promotes diabetes-associated centrosome amplification via increasing the expression of SKA1 directly at the transcriptional level. [Abstract]2019 Nov;234(11):20694-20703. PMID: 30989671 -
-
J Drug Target
Dual AMPK activation and TXNIP suppression underlie the superior anti-diabetic action of rosiglitazone-metformin co-crystal (RZM): evidence from preclinical models. [Abstract]2025 Jul 17:1-10. PMID: 40658109 -
Neuromolecular Med
Seipin Deficiency Impairs Motor Coordination in Mice by Compromising Spinal Cord Myelination. [Abstract]2025 Jan 27;27(1):12. PMID: 39869141 -
J Biol Chem
PPARγ and C/EBPα enable adipocyte differentiation upon inhibition of histone methyltransferase PRC2 in malignant tumors. [Abstract]2024 Sep 12:107765. PMID: 39276936 -
Sci Rep
2024 Apr 30;14(1):9960. PMID: 38693222 -
-
Prog Neuropsychopharmacol Biol Psychiatry
PPARγ/Adiponectin axis attenuates methamphetamine-induced conditional place preference via the hippocampal AdipoR1 signaling pathway. [Abstract]2023 Jul 13:125:110758. PMID: 36972780 -
Biomedicines
2021 Jun 15;9(6):677. PMID: 34203907 -
Clin Immunol
Elevated asprosin expression exacerbates synovial inflammation by PPAR-γ-dependent mechanisms in rheumatoid arthritis. [Abstract]2026 Apr:284:110677. PMID: 41638328 -
Food Sci Nutr
Anti-Diabetic Effects of Ayanin, a Flavonoid Compound, in STZ/HFD-Induced Diabetic Mice by Upregulating GLUT4 and Suppressing Macrophage-Driven Inflammation in Adipose Tissues. [Abstract]2026 Jan 7;14(1):e71429. PMID: 41509193 -
Food Sci Nutr
Screening Based on Structural and Biological Verification of Stachyose as a PPARγ-Modulating Ligand for the Treatment of Non-Alcoholic Fatty Liver Disease. [Abstract]2025 Sep 22;13(9):e71009. PMID: 40994455 -
Front Mol Neurosci
Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis. [Abstract]2017 Sep 14;10:293. PMID: 28959186
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Front Mol Neurosci. 2017 Sep 14;10:293. [Abstract]
Rosiglitazone enhances the phosphorylation of insulin receptor substrate 1 (IRS1, phosphorylated at Ser 636/639), which is considered to be the main activator of the Akt/mTOR pathway by IGF-1R.
-
Mol Cell Biochem
Decoding dexmedetomidine's multiple mechanisms in atherosclerosis: effects on lipid metabolism, inflammation, cholesterol efflux, and foam cell formation. [Abstract]2026 Mar 13. PMID: 41824202 -
Cell Signal
2022 May:93:110299. PMID: 35263629 -
Exp Cell Res
Molecular mechanism of MAFB transcriptional activation of PPARD in regulating adipose browning and protecting against vascular endothelial cell injury. [Abstract]2026 Jun 9;461(1):115102. PMID: 42264121 -
Exp Cell Res
Agarotetrol attenuates spinal cord injury by targeting PPARγ to modulate microglial activation. [Abstract]2026 May 1;458(1):114947. PMID: 41720447 -
-
Front Physiol
Chronic Unpredictable Mild Stress Promotes Atherosclerosis via HMGB1/TLR4-Mediated Downregulation of PPARγ/LXRα/ABCA1 in ApoE-/- Mice. [Abstract]2019 Mar 1:10:165. PMID: 30881312 -
Biochim Biophys Acta Mol Cell Biol Lipids
Regulation of adiponectin on lipid metabolism in large yellow croaker (Larimichthys crocea). [Abstract]2020 Aug;1865(8):158711. PMID: 32289502 -
Am J Physiol Endocrinol Metab
Glycogen synthesis is required for adaptive thermogenesis in beige adipose tissue and affects diet-induced obesity. [Abstract]2024 May 1;326(5):E696-E708. PMID: 38568151 -
PPAR Res
Peroxisome Proliferator-Activated Receptor γ Regulates Lipid Metabolism in Sheep Trophoblast Cells through mTOR Pathway-Mediated Autophagy. [Abstract]2023 Nov 8:2023:6422804. PMID: 38020065 -
PPAR Res
Activation of PPAR γ Protects Obese Mice from Acute Lung Injury by Inhibiting Endoplasmic Reticulum Stress and Promoting Mitochondrial Biogenesis. [Abstract]2022 Sep 28:2022:7888937. PMID: 36213491 -
Adipocyte
2021 Dec;10(1):646-657. PMID: 34793269 -
PPAR Res
Peroxisome Proliferator-Activated Receptor-γ Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p. [Abstract]2019 Jul 1:2019:2715176. PMID: 31354796 -
Ren Fail
Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner. [Abstract]2022 Dec;44(1):2056-2065. PMID: 36420656 -
Bioorg Med Chem
Design, synthesis, and biological evaluation of novel dual FFA1 and PPARδ agonists possessing phenoxyacetic acid scaffold. [Abstract]2022 Feb 15:56:116615. PMID: 35051813 -
J Therm Biol
Differential expression of ADRB1 causes different responses to norepinephrine in adipocytes of Duroc-Landrace-Yorkshire pigs and min pigs. [Abstract]2024 Jul 2:123:103906. PMID: 38970835 -
Front Vet Sci
Histological characteristics of hair follicles at different hair cycle and in vitro modeling of hair follicle-associated cells of yak ( Bos grunniens). [Abstract]2023 Nov 17:10:1277586. PMID: 38046572 -
Carcinogenesis
ACSL4: a Double-edged Sword Target in Multiple Myeloma, Promotes Cell Proliferation and Sensitizes Cell to Ferroptosis. [Abstract]2023 May 27;44(3):242-251. PMID: 36999754
Rosiglitazone sodium purchased from MedChemExpress. Usage Cited in: Carcinogenesis. 2023 May 27;44(3):242-251. [Abstract]
Rosiglitazone (ROSI; 15, 30, 60, 120, 240 µM; 24 h) significantly inhibits the growth of NCI-H929 and OPM-2 cells.
-
Am J Cancer Res
Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells. [Abstract]2020 Apr 1;10(4):1182-1193. PMID: 32368394 -
J Biochem Mol Toxicol
Protective Effect and Mechanism of Rosiglitazone in α-amanitin-induced Hepatotoxicity Via Activation of PPAR-γ/Nrf2 Signaling Pathway. [Abstract]2026 Feb;40(2):e70701. PMID: 41560421 -
J Biochem Mol Toxicol
Ferroptosis and Lipid Peroxidation Participate in Valproic Acid-Induced Hepatotoxicity via the Long-chain Acyl-CoA Synthetase 4/Glutathione Peroxidase 4 Pathway. [Abstract]2025 Oct;39(10):e70484. PMID: 40990894 -
BMC Gastroenterol
PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress. [Abstract]2025 Jan 20;25(1):22. PMID: 39833676 -
Fish Physiol Biochem
Promoting adipocyte hyperplasia ameliorates high-carbohydrate diet-induced inflammation, oxidative stress, and metabolic disorders and enhances growth performance and immune function in grass carp (Ctenopharyngodon idellus). [Abstract]2025 Feb 15;51(2):51. PMID: 39954189 -
J Cardiovasc Transl Res
TMAO Impairs Mouse Aortic Vasodilation by Inhibiting TRPV4 Channels in Endothelial Cells. [Abstract]2024 Dec;17(6):1415-1426. PMID: 38980653 -
Immunol Invest
Absence of TNF Leads to Alternative Activation in Peritoneal Macrophages in Experimental Listeria Monocytogenes Infection. [Abstract]2022 May;51(4):1005-1022. PMID: 33830841 -
Biochem Biophys Res Commun
PYCR2 contributes to sunitinib resistance in hepatocellular carcinoma by activating the PPAR signaling pathway. [Abstract]2026 Jul 23:823:153971. PMID: 42155340 -
Biochem Biophys Res Commun
2024 Nov 26:735:150865. PMID: 39442449 -
Biochemistry (Mosc)
2021 May;86(5):568-576. PMID: 33993864 -
Biochem Biophys Res Commun
Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression. [Abstract]2020 Mar 26;524(1):70-76. PMID: 31980182 -
Endocr J
Rutin promotes white adipose tissue "browning" and brown adipose tissue activation partially through the calmodulin-dependent protein kinase kinase β/AMP-activated protein kinase pathway. [Abstract]2022 Apr 28;69(4):385-397. PMID: 34719526 -
Kidney Blood Press Res
Renal NKCC2 Is Dual Regulated by the Synergy of 20-HETE and High-Fat Diet in CYP4F2 Transgenic Mice. [Abstract]2021;46(5):601-612. PMID: 34320496 -
Stem Cells Dev
miR-1275 inhibits human omental adipose-derived stem cells differentiation towards the beige phenotype via PRDM16. [Abstract]2022 Dec;31(23-24):799-809. PMID: 36128801 -
Orthod Craniofac Res
Compressive Stress and Inflammation Induce Ferroptosis in Periodontal Ligament Cells Through ACSL4 Activation in Orthodontically Induced Inflammatory Root Resorption. [Abstract]2025 Jun 28. PMID: 40579979 -
Reprod Domest Anim
2023 Nov;58(11):1559-1568. PMID: 37712626 -
Open Med
ACSL4 mediates inflammatory bowel disease and contributes to LPS-induced intestinal epithelial cell dysfunction by activating ferroptosis and inflammation. [Abstract]2024 Sep 3;19(1):20240993. PMID: 39247444 -
Curr Med Sci
Huaier Aqueous Extract Combined with Gefitinib Promotes ACSL4-Dependent Ferroptosis and Overcomes Gefitinib Resistance in Non-Small Cell Lung Cancer. [Abstract]2026 Feb;46(1):197-211. PMID: 41557244 -
bioRxiv
2025 Nov 3:2025.10.31.685966. PMID: 41279778 -
-
-
-
-
-
-
-
-
Oxid Med Cell Longev
Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization. [Abstract]2021 Oct 14;2021:5527137. PMID: 34691355 -
-
Protocol
cDNA encoding amino acids 174-475 of PPARγ1 is amplified via polymerase chain reaction and inserted into bacterial expression vector pGEX-2T. GST-PPARγ LBD is expressed in BL21(DE3)plysS cells and extracts. For saturation binding analysis, bacterial extracts (100 μg of protein) are incubated at 4°C for 3 h in buffer containing 10 mM Tris (pH 8.0), 50 mM KCl, 10 mM dithiothreitol with [3H]-BRL49653 (specific activity, 40 Ci/mmol) in the presence or absence of unlabeled Rosiglitazone. Bound is separated from free radioactivity by elution through 1-mL Sephadex G-25 desalting columns. Bound radioactivity eluted in the column void volume and is quantitated by liquid scintillation counting[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
C3H10T1/2 cells are grown in a 24-well plate in DME medium supplemented with 10% fetal calf serum. Medium and compound (Rosiglitazone) are exchanged every 3 days. Cells are stained at day 7 with Oil Red O and photographed[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Rats are intravenously injected with 38 mg/kg streptozotocin and after 48 h, diabetes is identified by urinary glucosuria and then random blood sugar is measured and this day is regarded as day 0. Animals with a serum glucose level of 220-300 mg/dL are selected to be used in this study. Rats are randomly separated into five groups for daily drug administration for 8 weeks: group 1: control nondiabetic rats given a vehicle only (0.5 mL/kg of 0.5% carboxy methyl celleluse orally), group 2: control diabetic rats given a vehicle, group 3: diabetic rats receiving Rosiglitazone (5 mg/kg orally), group 4: diabetic rats receiving losartan (2 mg/kg, orally), and group 5: diabetic rats receiving both Rosiglitazone and losartan[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
References
[1]. Lehmann JM, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995 Jun 2;270(22):12953-6. [Content Brief]
[2]. Willson TM, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996 Feb 2;39(3):665-8. [Content Brief]
[3]. Thouennon E, et al. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection. J Neurochem. 2015 Aug;134(3):463-70. [Content Brief]
[4]. Majeed Y, et al. Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol. 2011 Jun;79(6):1023-30. [Content Brief]
[5]. Ateyya H, et al. Beneficial effects of rosiglitazone and losartan combination in diabetic rats. Can J Physiol Pharmacol. 2018 Mar;96(3):215-220. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)